CE vs KRO vs DQ Stock Comparison

Celanese, Kronos Worldwide and Daqo New Energy Prices as of Oct 27, 2026 Peers: Industry group
1 more company in this comparison (OLN) Create a free account to keep reading and compare up to 10 companies.
CE Celanese Corp
$48.63 +3.3% 1M +10.9% 1Y
Market cap
$5.34B
P/E
–
Revenue (TTM)
$9.71B
Div. yield
0.31%
Commodity Chemicals Basic Materials
3 wins
KRO Kronos Worldwide Inc
$7.74 -6.2% 1M +56.4% 1Y
Market cap
$890.85M
P/E
–
Revenue (TTM)
$1.94B
Div. yield
2.58%
Commodity Chemicals Basic Materials
7 wins
DQ Daqo New Energy Corp.
$11.02 -3.9% 1M -62.9% 1Y
Market cap
$745.68M
P/E
–
Revenue (TTM)
$555.69M
Div. yield
–
Commodity Chemicals Basic Materials
1 win

Head to Head

11 decided of 12

Kronos Worldwide leads on 7 of the 12 questions below (Kronos Worldwide 7, Celanese 3, Daqo New Energy 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCEKRODQLeader
Larger companyMarket capitalisation $5.34B $890.85M $745.68M CE
Cheaper on earningsLower P/E, profitable companies only -4.6x -8.1x -2.9x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 7.7x 20.4x — CE
Faster revenue growthRevenue growth, trailing twelve months -2.2% +2.7% -6.3% KRO
More profitableNet margin, trailing twelve months -12.0% -5.6% -46.6% KRO
Better return on capitalReturn on invested capital -4.1% -2.4% — KRO
Less leveragedLower net debt / EBITDA 63.7x 17.7x — KRO
Higher dividend yieldTrailing dividend yield 0.31% 2.58% — KRO
Better 1-year returnPrice return, last 12 months +10.9% +56.4% -62.9% KRO
Better 5-year returnAnnualised price return, 5 years -21.7%/yr -10.1%/yr -32.1%/yr KRO
Less volatileAnnualised volatility, 1 year 51.7% 59.1% 56.6% CE
Higher overall scoreMean of the five percentile scores vs peers 31/100 42/100 48/100 DQ

Percentile Scorecard

CEKRODQ

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCEKRODQ
Valuation 58 #40 of 94 70 #29 of 94 44 #53 of 94
Growth 23 #70 of 91 38 #57 of 91 36 #59 of 91
Profitability 33 #58 of 86 29 #61 of 86 14 #74 of 86
Financial Health 13 #83 of 95 38 #59 of 95 98 #3 of 95
Shareholder Returns 26 #52 of 70 35 #46 of 70 –
Overall 31 42 48
  • CE ranked among 99 companies in Chemicals
  • KRO ranked among 99 companies in Chemicals
  • DQ ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCEKRODQSPY
1 month +3.3%-6.2%-3.9% -0.2%
3 months +11.7%+25.2%-7.1% +3.9%
6 months -24.8%+7.4%-49.8% +8.2%
Year to date +15.0%+75.1%-62.6% +12.9%
1 year +10.9%+56.4%-62.9% +12.3%
3 years -57.2%+16.4%-52.8% +87.4%
3 years, per year -24.6%+5.2%-22.1% +23.3%
5 years -70.6%-41.1%-85.6% +67.9%
5 years, per year -21.7%-10.1%-32.1% +10.9%
10 years -32.2%+0.5%+134.9% +261.1%
10 years, per year -3.8%+0.1%+8.9% +13.7%

Risk

MeasureCEKRODQSPY
Volatility, 1Y 51.7%59.1%56.6% 12.7%
Downside volatility, 1Y 47.1%47.7%55.9% 12.7%
Beta vs S&P 500, 1Y 0.401.261.57 1.00
Return / volatility, 1Y 0.210.95-1.11 0.97
Max drawdown, 5Y -79.6%-77.9%-87.0% -25.4%
From 52-week high -29.8%-13.1%-69.1% -1.2%
52-week high $69.24$8.91$35.69 $779.14
52-week low $35.53$4.33$10.09 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCEKRODQ
P/E now vs peer median -4.6xmedian 22.0x -8.1xmedian 22.0x -2.9xmedian 22.0x
P/S now vs peer median 0.5xmedian 1.4x 0.5xmedian 1.4x 1.3xmedian 1.4x
EV/EBITDA now vs peer median 95.7xmedian 12.4x 46.9xmedian 12.4x —median 12.4x
P/FCF now vs peer median 7.5xmedian 15.1x 13.4xmedian 15.1x -2.3xmedian 15.1x
P/B now vs peer median 1.2xmedian 1.6x 1.2xmedian 1.6x 0.1xmedian 1.6x
PEG now vs peer median 0.11median 1.66 0.19median 1.66 0.09median 1.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCEKRODQ
Revenue $9.71B $1.94B $555.69M
Gross profit $2.03B $229.50M -$196.98M
Operating income -$692.00M -$32.10M -$290.08M
Net income -$1.16B -$109.40M -$258.74M
Free cash flow $708.00M $66.50M -$326.78M
R&D $120.00M – $3.61M
EPS (diluted) $-10.60 $-0.95 $-3.84
Cash & equivalents $1.36B $26.60M $555.32M
Total debt $12.01B $569.60M –
Shares (diluted) 110.25M 115.10M 67.35M
Enterprise value -$66.91M $777.65M -$2.23B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCEKRODQ
P/E -4.6x -8.1x -2.9x
P/FCF 7.5x 13.4x -2.3x
P/Operating cash flow 5.4x 10.3x -6.2x
P/S 0.5x 0.5x 1.3x
P/B 1.2x 1.2x 0.1x
P/Tangible book 3.5x 1.2x 0.1x
EV/EBITDA 95.7x 46.9x –
EV/EBIT -23.1x -44.7x 0.2x
EV/Revenue 1.6x 0.7x -0.1x
EV/FCF 22.6x 21.6x 0.2x
EV/Operating cash flow 16.2x 16.6x 0.5x
PEG (3Y EPS CAGR) 0.11 0.19 0.09

Growth

14 metrics
MetricCEKRODQ
Revenue growth (1Y) -2.2% 2.7% -6.3%
Revenue CAGR (3Y) -1.9% 5.1% -45.5%
Gross profit growth (1Y) -5.7% -35.8% 31.8%
Gross profit CAGR (3Y) -3.3% 5.4% -27.7%
Operating income growth (1Y) 11.1% -128.3% 53.8%
Operating income CAGR (3Y) -39.7% -32.2% -29.0%
Net income growth (1Y) 29.1% -262.1% 49.2%
Net income CAGR (3Y) -42.8% -69.9% -29.3%
EPS growth (1Y) 29.0% -261.9% 50.1%
EPS CAGR (3Y) -42.8% -43.1% -31.6%
Operating cash flow growth (1Y) -3.5% 2,202% 53.8%
Operating cash flow CAGR (3Y) -16.2% 58.1% –
Free cash flow growth (1Y) 12.0% 236.6% 60.4%
Free cash flow CAGR (3Y) -13.2% 37.5% -33.9%

Profitability

14 metrics
MetricCEKRODQ
Gross margin 20.9% 11.8% -35.4%
EBITDA margin 1.7% 1.6% –
Operating margin -7.1% -1.7% -52.2%
Pretax margin -11.6% -5.0% -46.7%
Net margin -12.0% -5.6% -46.6%
FCF margin 7.3% 3.4% -58.8%
Operating cash flow margin 10.1% 4.4% -21.8%
Return on equity -25.4% -14.6% -4.4%
Return on assets -5.3% -6.2% -4.1%
Return on invested capital -4.1% -2.4% –
Return on capital employed -3.9% -2.2% -4.9%
Asset turnover 0.5x 1.1x 0.1x
Cash conversion (OCF / net income) -0.8x -0.8x 0.5x
Stock comp / revenue 0.3% – –

Financial Health

11 metrics
MetricCEKRODQ
Debt / assets 56.1% 32.7% –
Debt / equity 2.6x 0.8x –
Net debt / EBITDA 63.7x 17.7x –
Debt / FCF 17.0x 8.6x –
Liabilities / assets 78.6% 56.9% 7.5%
Equity / assets 21.4% 43.1% 92.5%
Interest coverage -1.0x -0.6x –
Current ratio 1.4x 3.3x 5.8x
Quick ratio 0.8x 1.5x 2.0x
Cash ratio 0.3x 0.1x 1.8x
Altman Z-score 1.29 1.77 –

Shareholder Returns

7 metrics
MetricCEKRODQ
Dividend yield 0.3% 2.6% –
Net buyback yield – – –
Shareholder yield 0.3% 2.6% –
Payout ratio (earnings) -1.1% -21.0% –
Payout ratio (FCF) 1.8% 34.6% –
Dividend growth (1Y) -91.8% 0.0% –
Dividend CAGR (3Y) -65.0% -36.0% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCEKRODQ
Forward P/E 7.7xFY2026 20.4xFY2026 –
EPS, next fiscal year $6.33FY2026 $0.38FY2026 $-4.14FY2026
EPS growth, next FY +59.0%FY2026 – –
EPS growth, the year after -0.2% +63.2% –
Revenue, next fiscal year $9.75BFY2026 $2.13BFY2026 $764.55MFY2027
Revenue growth, next FY +2.2%FY2026 +14.3%FY2026 +14.9%FY2027
Revenue growth, the year after +7.8% -4.3% +19.5%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCEKRODQ
Held by institutions 100.0% 16.0% 45.4%
Institutions holding 458 130 115
Change in shares held, QoQ +10.8% +4.6% +11.7%
Institutions buying 246 74 61
Institutions selling 138 34 36
Buyers to sellers 1.78 2.18 1.69

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CEKRODQ
CE 1.00 0.39 0.13
KRO 0.39 1.00 0.12
DQ 0.13 0.12 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CE, KRO and DQ?

Celanese (CE) is the largest by market capitalisation: Celanese (CE) $5.34B, Kronos Worldwide (KRO) $890.85M, Daqo New Energy (DQ) $745.68M.

Which company is growing faster?

Kronos Worldwide (KRO) grew revenue fastest over the trailing twelve months: Celanese (CE) -2.2%, Kronos Worldwide (KRO) +2.7%, Daqo New Energy (DQ) -6.3%.

Which company is more profitable?

Kronos Worldwide (KRO) has the highest net margin (Celanese (CE) -12.0%, Kronos Worldwide (KRO) -5.6%, Daqo New Energy (DQ) -46.6%). On return on invested capital, Kronos Worldwide (KRO) leads (Celanese (CE) -4.1%, Kronos Worldwide (KRO) -2.4%).

Which stock has performed better?

Over the past year Kronos Worldwide (KRO) returned the most: Celanese (CE) +10.9%, Kronos Worldwide (KRO) +56.4%, Daqo New Energy (DQ) -62.9%. Over five years, Kronos Worldwide (KRO) compounded fastest (Celanese (CE) -21.7%/yr, Kronos Worldwide (KRO) -10.1%/yr, Daqo New Energy (DQ) -32.1%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Kronos Worldwide (KRO) has the highest dividend yield: Celanese (CE) 0.31%, Kronos Worldwide (KRO) 2.58%. Daqo New Energy (DQ) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Celanese (CE) has been the steadiest (Celanese (CE) 51.7%, Kronos Worldwide (KRO) 59.1%, Daqo New Energy (DQ) 56.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CE, KRO and DQ?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Kronos Worldwide (KRO) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.